Condition: Advanced Cancer · Metastatic Cancer · Ovarian Cancer · Sponsor: Artios Pharma Ltd
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more about the side effects of ART0380 alone and in combination with gemcitabine or irinotecan * Learn more about the effectiveness of ART0380 alone and in combination with gemcitabine or irinotecan
This description comes directly from the study's public registry record.
Sarah Cannon Development Innovations · 844-710-6157 · SCRI.InnovationsMedical@scri.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Mayo Clinic (Arizona) | Scottsdale, Arizona, United States | Recruiting |
| University of Arkansas - Winthrop P. Rockefeller Cancer Institute | Little Rock, Arkansas, United States | Recruiting |
| USC Norris Comprehensive Cancer Center | Los Angeles, California, United States | Recruiting |
| Sansum Clinic | Santa Barbara, California, United States | Recruiting |
| Providence Medical Foundation | Santa Rosa, California, United States | Recruiting |
| Rocky Mountain Cancer Center | Denver, Colorado, United States | Recruiting |
| Sarah Cannon Research Institute at HealthONE | Denver, Colorado, United States | Recruiting |
| Florida Cancer Specialists | Fort Myers, Florida, United States | Recruiting |
| Mayo Clinic (Florida) | Jacksonville, Florida, United States | Recruiting |
| Cancer Specialists of North Florida | Jacksonville, Florida, United States | Recruiting |
| Florida Cancer Specialists | Orlando, Florida, United States | Completed |
+ 67 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04657068